Cargando…
The skeletal muscle phenotype of the DE50-MD dog model of Duchenne muscular dystrophy
Background: Animal models of Duchenne muscular dystrophy (DMD) are essential to study disease progression and assess efficacy of therapeutic intervention, however dystrophic mice fail to display a clinically relevant phenotype, limiting translational utility. Dystrophin-deficient dogs exhibit diseas...
Autores principales: | Hildyard, John C.W., Riddell, Dominique O., Harron, Rachel C.M., Rawson, Faye, Foster, Emma M.A., Massey, Claire, Taylor-Brown, Frances, Wells, Dominic J., Piercy, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971692/ https://www.ncbi.nlm.nih.gov/pubmed/36865375 http://dx.doi.org/10.12688/wellcomeopenres.18251.1 |
Ejemplares similares
-
Serum inflammatory cytokines as disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy
por: Riddell, Dominique O., et al.
Publicado: (2022) -
Longitudinal assessment of blood-borne musculoskeletal disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy
por: Riddell, Dominique O., et al.
Publicado: (2022) -
Validation of DE50-MD dogs as a model for the brain phenotype of Duchenne muscular dystrophy
por: Crawford, Abbe H., et al.
Publicado: (2022) -
Musculoskeletal magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy
por: Hornby, Natasha L., et al.
Publicado: (2021) -
Investigating Synthetic Oligonucleotide Targeting of Mir31 in Duchenne Muscular Dystrophy
por: Hildyard, John CW, et al.
Publicado: (2016)